-
2
-
-
0027232713
-
Neuroleptics, learning disabilities and the community: Some history and mystery
-
Manchester D. Neuroleptics, learning disabilities and the community: some history and mystery. BMJ 1993; 307: 184-187
-
(1993)
BMJ
, vol.307
, pp. 184-187
-
-
Manchester, D.1
-
3
-
-
0033659858
-
Receipt of psychotropic medication by people with intellectual disability in residential settings
-
Robertson J, Emerson E, Gregory N, Hatton C, Kessissiglou S, Hallam A. Receipt of psychotropic medication by people with intellectual disability in residential settings. J Intellectual Disability Res 2002; 44: 666-676
-
(2002)
J Intellectual Disability Res
, vol.44
, pp. 666-676
-
-
Robertson, J.1
Emerson, E.2
Gregory, N.3
Hatton, C.4
Kessissiglou, S.5
Hallam, A.6
-
4
-
-
0029817887
-
Factors associated with the successful or unsuccessful withdrawal of antipsychotic drug therapy prescribed for people with learning disabilities
-
Branford D. Factors associated with the successful or unsuccessful withdrawal of antipsychotic drug therapy prescribed for people with learning disabilities J Intellectual Disability Research 1996; 40: 322-329
-
(1996)
J Intellectual Disability Research
, vol.40
, pp. 322-329
-
-
Branford, D.1
-
5
-
-
0033984232
-
Reducing antipsychotic medication in people with a learning disability
-
Ahmed Z, Fraser W, Kerr MP et al. Reducing antipsychotic medication in people with a learning disability. Br J Psychiat 2000; 176: 42-46
-
(2000)
Br J Psychiat
, vol.176
, pp. 42-46
-
-
Ahmed, Z.1
Fraser, W.2
Kerr, M.P.3
-
6
-
-
0033438556
-
Prescription of psychotropic medication to people with intellectual disabilities in primary health care settings
-
Molyneaux P, Emerson E, Caine A. Prescription of psychotropic medication to people with intellectual disabilities in primary health care settings. J App Res Intellectual Disability 2000; 12: 46-57
-
(2000)
J App Res Intellectual Disability
, vol.12
, pp. 46-57
-
-
Molyneaux, P.1
Emerson, E.2
Caine, A.3
-
7
-
-
0029551709
-
A study of the clinical outcomes of patients with profound mental retardation gradually withdrawn from chronic neuroleptic medication
-
May P, London EB, Zimmerman T, Thompson R, Mento AB, Spreat S. A study of the clinical outcomes of patients with profound mental retardation gradually withdrawn from chronic neuroleptic medication. Ann Clin Psychiatry 1995; 7: 155-160.
-
(1995)
Ann Clin Psychiatry
, vol.7
, pp. 155-160
-
-
May, P.1
London, E.B.2
Zimmerman, T.3
Thompson, R.4
Mento, A.B.5
Spreat, S.6
-
8
-
-
0032700378
-
Antipsychotic medication for challenging behaviour in people with learning disability: A systematic review of randomised controlled trials
-
Brylewski J, Duggan L. Antipsychotic medication for challenging behaviour in people with learning disability: a systematic review of randomised controlled trials. J Intellectual Disability Res 1999; 43: 360-371
-
(1999)
J Intellectual Disability Res
, vol.43
, pp. 360-371
-
-
Brylewski, J.1
Duggan, L.2
-
10
-
-
0034712552
-
QTC interval abnormalities and psychotropic drug therapy in psychiatric patients
-
Reilly JG, Ayis SA, Ferrier IN, Jones SJ, Thomas SHL. QTC interval abnormalities and psychotropic drug therapy in psychiatric patients. Lancet 2000; 355: 1048-1052.
-
(2000)
Lancet
, vol.355
, pp. 1048-1052
-
-
Reilly, J.G.1
Ayis, S.A.2
Ferrier, I.N.3
Jones, S.J.4
Thomas, S.H.L.5
-
11
-
-
0037048987
-
Cardiac arrest and ventricular arrhythmia in patients taking antipsychotic drugs: Cohort study using administrative data
-
Hennessy S, Bilker Wb, Knauss JS et al. Cardiac arrest and ventricular arrhythmia in patients taking antipsychotic drugs: cohort study using administrative data. BMJ 2002; 325: 1070-1072
-
(2002)
BMJ
, vol.325
, pp. 1070-1072
-
-
Hennessy, S.1
Bilker, Wb.2
Knauss, J.S.3
-
12
-
-
0036263960
-
Thioridazine and sudden unexplained death in psychiatric in-patients
-
Reilly JG, Ayis A, Ferrier N, Jones SJ, Thomas SHL. Thioridazine and sudden unexplained death in psychiatric in-patients. Br J Psychiat 2002; 180: 515-522
-
(2002)
Br J Psychiat
, vol.180
, pp. 515-522
-
-
Reilly, J.G.1
Ayis, A.2
Ferrier, N.3
Jones, S.J.4
Thomas, S.H.L.5
-
13
-
-
0037157547
-
Discontinuation of thioridazine in patients with learning disabilities: Balancing cardiovascular toxicity with adverse consequences of changing drugs
-
Davies, SJC, Cooke LB, Moore AG, Potokar J. Discontinuation of thioridazine in patients with learning disabilities: balancing cardiovascular toxicity with adverse consequences of changing drugs. BMJ 2002; 324: 1519-1521
-
(2002)
BMJ
, vol.324
, pp. 1519-1521
-
-
Davies, S.J.C.1
Cooke, L.B.2
Moore, A.G.3
Potokar, J.4
-
14
-
-
85044702863
-
Discontinuation of thioridazine: What happened to thioridazine?
-
Arshad P, Morcos M, Stidharan B. Discontinuation of thioridazine: what happened to thioridazine? BMJ 2002; 325: 968
-
(2002)
BMJ
, vol.325
, pp. 968
-
-
Arshad, P.1
Morcos, M.2
Stidharan, B.3
-
17
-
-
0037180226
-
Discontinuation of thioridazine: Risks must be balanced
-
Bisset AF. Discontinuation of thioridazine: risks must be balanced. BMJ 2002; 325, 967-968
-
(2002)
BMJ
, vol.325
, pp. 967-968
-
-
Bisset, A.F.1
-
18
-
-
18544365479
-
Sedation effects on responsiveness: Evaluating the reduction of antipsychotic medication in people with intellectual disability using a conditional probability approach
-
Smith C, Felce D, Ahmed Z et al. Sedation effects on responsiveness: evaluating the reduction of antipsychotic medication in people with intellectual disability using a conditional probability approach. J Intellectual Disability Res 2002; 46: 464-471
-
(2002)
J Intellectual Disability Res
, vol.46
, pp. 464-471
-
-
Smith, C.1
Felce, D.2
Ahmed, Z.3
-
19
-
-
0024327355
-
Schizophrenia and mental handicap: An historical review, with implications for further research
-
Turner TH. Schizophrenia and mental handicap: an historical review, with implications for further research. Psych Med 1989; 19: 301-314
-
(1989)
Psych Med
, vol.19
, pp. 301-314
-
-
Turner, T.H.1
|